The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats

General Physiology and Biophysics

Volumn 27, Issue 4, 2008, Pages 291-298

  Kuželová, Magdaléna ^a   Adameová, Adriana ^a   Sumbalová, Zuzana ^b   Paulíková, Ingrid ^a   Harčárová, Anna ^a   Švec, Pavel ^a   Kucharská, Jarmila ^b  

^a Faculty of Natural Sciences   (Slovakia)

^b Bratislava   (Slovakia)

Author keywords

tocopherol; Coenzyme Q; Experimental diabetic hypercholesterolaemia; Lipid peroxidation; Simvastatin

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; GLUCOSE; SIMVASTATIN; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIVER LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; ORGAN SPECIFICITY; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, WISTAR; SIMVASTATIN; UBIQUINONE;

ANIMALIA; RATTUS;

EID: 60149092000     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Adameová A., Kuželová M., Faberová V., Švec P. (2006): Protective effect of simvastatin and VULM 1457 in ischaemic-reperfused myocardium of the diabetic-hypercholesterolemic rats. Pharmazie 61, 807-808
2. Bargossi A. M., Grossi G., Fiorella P. L., Gaddi A., Di Giulio R., Battino M. (1994): Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. Mol. Aspects Med. 15, 187-193
3. Bleske B. E., Willis R. A., Anthony M., Casselberry N., Datwani M., Uhley V. E., Secontine S. G., Shea M. J. (2001): The effect of pravastatin and atorvastatin on coenzyme Q10. Am. Heart J. 142, E2
4. Bolayirli I. B., Aslan M., Balci H., Altug T., Hacibekiroglu M., Seven A. (2007): Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sci. 81, 121-127
5. Crane F. L. (2001): Biochemical functions of coenzyme Q 10. J. Am. Coll. Nutr. 20, 591-598
6. Davignon J., Jacob R.F., Mason R.P. (2004): The antioxidant effects of statins. Coron. Artery Dis. 15, 251-258
7. Ferko M., Gvozdjaková A., Kucharská J., Mujkošová J., Waczulíková I., Styk J., Ravingerová T., Ziegelhöffer-Mihalovičová B., Ziegelhöffer A. (2006): Functional remodeling of heart mitochondria in acute diabetes: interrelationships between damage, endogenous protection and adaptation. Gen. Physiol. Biophys. 25, 397-413
8. Folkers K., Langsjoen P., Willis R., Richardson P., Xia L.-J., Ye Ch.-Q., Tamagawa H. (1990): Lovastatin decreases coenzyme Q levels in humans. Proc. Natl. Acad. Sci. U.S.A. 87, 8931-8934
9. Fukami M., Maeda N., Fukushige J., Kogure Y., Shimada Y., Ogawa T., Tsujita Y. (1993): Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits. Res. Exp. Med. (Berl.) 193, 263-273
10. Hanaki Y., Sugiyama S., Ozawa T., Ohno M. (1993): Coenzyme Q10 and coronary artery disease. Clin. Invest. 71, S112-115
11. Hargreaves I. P. (2003): Ubiquinone: cholesterol's reclusive cousin. Ann. Clin. Biochem. 40, 207-218
12. 10. Possible biochemical/clinical implication. Drug Saf. 28, 1-18
13. Hermans N., Cos P., De Meyer G. R., Maes L., Pieters L., Vanden Berghe D., Vlietinck A. J., De Bruyne T. (2007): Study of potential systemic oxidative stress animal models for the evaluation of antioxidant activity: status of lipid peroxidation and fat-soluble antioxidants. J. Pharm. Pharmacol. 59, 131-136
14. Jain S. K., Levine S. N. (1995): Elevated lipid peroxidation and vitamine E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats. Free Radic. Biol. Med. 18, 337-341
15. Jiao S., Matsuzawa Y., Matsubara K., Kihara S., Nakamura T., Tokunaga K., Kubo M., Tarui S. (1988): Increased activity of intestinal acyl-CoA: cholesterol acyltransferase in rats with streptozocin-induced diabetes and restoration by insulin supplementation. Diabetes 37, 342-346
16. Kagan V. E., Fabisiak Y. P., Tyurina Y. Y. (2000): Independent and concerted antioxidant functions of coenzyme Q. In: Coenzyme Q: Molecular Mechanisms in Health and Disease. (Eds. V. E. Kagan and D. J. Quinn), pp. 119-129, CRC Press, Boca Raton
17. Kettawan A., Takahashi T., Kongkachuichai R., Charoenkiatkul S., Kishi T., Okamoto T. (2007): Protective effects of coenzyme Q10 on decrease oxidative stress resistance induced by simvastatin. J. Clin. Biochem. Nutr. 40, 194-202
18. Kucharská J., Braunová Z., Uličná O., Zlatoš L., Gvozdjáková A. (2000): Deficit of coenzyme Q in heart and liver mitochondria of rats with streptozotocin-induced diabetes. Physiol. Res. 49, 411-418
19. Kucharska J., Gvozdjakova A., Stefek M., Sotnikova R., Sumbalova Z. (2001): Adaptive changes of antioxidant status in development of experimental diabetes. Bratisl. Lek. Listy 102, 515-519
20. Kucharska J., Gvozdjakova A., Simko F. (2007): Simvastatin decreased coenzyme Q in the left ventricle and skeletal muscle but not in the brain and liver in L-NAME-induced hypertension. Physiol. Res. 56 (Suppl. 2), S49-54
21. Kusunoki J., Aragane K., Kitamine T., Kozono H., Kano K., Fujinami K., Kojima K., Chiwata T., Sekine Y. (2000): Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A: cholesterol acyltransferase activity. Arterioscler. Thromb. Vasc. Biol. 20, 171-178
22. Laaksonen R., Jokelainen K., Sahi T., Tikkanen M. J., Himberg J. J. (1995): Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin. Pharmacol. Ther. 57, 62-66
23. Laaksonen R., Jokelainen K., Laakso J., Sahi T., Harkonen M., Tikkanen M. J., Himberg J. J. (1996): The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. Am. J. Cardiol. 77, 851-854
24. Lang J. K., Gohil K., Packer L. (1986): Simultaneous determination of tocopherol ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal. Biochem. 157, 106-116
25. Langsjoen P. H., Langsjoen A. M. (2003): The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. Biofactors 18, 101-111
26. Littarru G. P., Langsjoen P. (2007): Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 7, S168-174
27. Mabuchi H., Higashikata T., Kawashiri M., Katsuda S., Mizuno M., Nohara A., Inazu A., Koizumi J., Kobayashi J. (2005): Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. J. Atheroscler. Thromb. 12, 111-119
28. Miyake Y., Shouzu A., Nishikawa M., Yonemoto T., Shimizu H., Omoto S., Hayakawa T., Inada M. (1999): Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneim.-Forsch. 49, 324-329
29. Mortensen S. A., Leth A., Agner E., Rohde M. (1997): Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol. Aspects Med. 18, S137-144
30. Nakahara K., Kuriyama M., Sonoda Y., Yoshidome H., Nakagawa H., Fujiyama J., Higuchi I., Osame M. (1998): Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study. Toxicol. Appl. Pharmacol. 152, 99-106
31. Nawarskas J. J. (2005): HMG-CoA reductase inhibitors and coenzyme Q10. Cardiol. Rev. 13, 76-79
32. Ohkawa H., Ohishi N., Yagi K. (1979): Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358
33. Parker R.A., Huang Q., Tesfamariam B. (2003): Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature. Atherosclerosis 169, 19-29
34. Passi S., Stancato A., Aleo E., Dmitrieva A., Littarru G. P. (2003): Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors 18, 113-124
35. Riad A., Du J., Stiehl S., Westermann D., Mohr Z., Sobirey M., Doehner W., Adams V., Pauschinger M., Schultheiss H. P., Tschope C. (2007): Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. Eur. J. Pharmacol. 569, 204-211
36. Rundek T., Naini A., Sacco R., Coates K., DiMauro S. (2004): Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch. Neurol. 61, 889-892
37. Salardi S., Zucchini S., Elleri D., Grossi G., Bargossi A. M., Gualandi S., Santoni R., Cicognani A., Cacciari E. (2004): High glucose levels induce an increase in membrane antioxidants, in terms of vitamin E and coenzyme Q10, in children and adolescents with type 1 diabetes. Diabetes Care 27, 630-631
38. Sarter B. (2002): Coenzyme Q10 and cardiovascular disease: a review. J. Cardiovasc. Nurs. 16, 9-20
39. Shin M. J., Chung N., Lee J. H., Jang Y., Park E., Jeon K. I., Chung J. H., Seo B. Y. (2007): Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolaemic patients. Int. J. Cardiol. 118, 173-177
40. Stefek M., Sotnikova R., Okruhlicova L., Volkovova K., Kucharska J., Gajdosik A., Gajdosikova A., Mihalova D., Hozova R., Tribulova N., Gvozdjakova A. (2000): Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol. 37, 111-117
41. Uličná O., Volkovová K., Ištvánová B. (1996): Bioenergetics of liver mitochondria in rats inexperimental insulin-dependent diabetes. Bratisl. Lek. Listy 97, 619-624 (in Slovak)
42. Willis R. A., Folkers K., Tucker J. L., Ye Ch.-Q., Xia L.-J., Tamagawa H. (1990): Lovastatin decreases coenzyme Q levels in rats. Proc. Natl. Acad. Sci. U.S.A. 87, 8928-8930
43. Wittenstein B., Klein M., Finckh B., Ullrich K., Kohlschutter A. (2002): Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic. Biol. Med. 33, 103-110
44. Yalcin A., Kilinc E., Sagcan A., Kultursay H. (2004): Coenzyme Q10 concentrations in coronary artery disease. Clin. Biochem. 37, 706-709
45. Ziegelhöffer A. (2007): Cogitation about free radicals and oxidative stress - an old concept with many new limitations. (Editorial) Gen. Physiol. Biophys. 26, 71-74